Liquid Biopsy Promotes Precision Medicine By Tracking Patient’s Cancer

In a study published in Nature Communications, Dr. Muhammed Murtaza, who holds a joint appointment at Mayo Clinic and Translational Genomics Research Institute (TGEN), and colleagues, describe an extensive comparison between biopsy results and analysis of ctDNA in a patient with breast cancer.

In the following video, Dr. Murtaza describes how circulating tumor DNA in blood could inform physicians on best treatments for individual patients.

For more information, visit:
►Mayo Clinic Center for Individualized Medicine: http://mayoresearch.mayo.edu/center-for-individualized-medicine/?mc_id=us&utm_source=youtube&utm_medium=sm&utm_content=video&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100504
►TGEN: https://tgen.org/home/news/2015-media-releases/tgen-shows-liquid-biopsies-could-help-cancer-patients.aspx#.VjooyWdRGUl

source

Tags

Leave a Reply

Your email address will not be published. Required fields are marked *